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Abstract A murine carbonic anhydrase-related protein (CARP) 
has been expressed in Escherichia coli and purified to near 
homogeneity. The polypeptide chain consists of 290 amino acid 
residues and has a calculated molecular mass of 32 950 Da. By 
introducing two mutations, Arg 117 --*His and Ginll5---~ Gin, we 
created a metal-binding center homologous to that in the 
carbonic anhydrases from the animal kingdom. In contrast to 
unmodified CARP, this double mutant was isolated as a 1 : 1 
zinc-protein complex. While unmodified CARP is catalytically 
inactive, the mutant catalyzes CO2 hydration with a significantly 
higher efficiency than the mammalian low-activity carbonic 
anhydrase isozyme III. The activity is strongly inhibited by the 
powerful and selective carbonic anhydrase inhibitor, acetazol- 
amide. 
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idues. This sequence segment has no counterpart in any iso- 
zyme form of CA, and its function is unknown. The 
remainder of the sequence shows 30-40% identity with se- 
quences of different mammalian CA isozymes [5]. Moreover, 
26 of the 28 residues, that are invariant in all sequenced ani- 
mal CAs, are also found in CARP. The two exceptions are 
located in the active site of CA. Thus, the zinc ligand His 94 
corresponds to Arg I17 in mouse CARP. In addition, Gin 9s, 
which forms a hydrogen bond with His 94 in CA, corresponds 
to Glu 115 in CARP. 
We have used site-specific mutagenesis to replace Arg 117 
and Glu 115 in CARP with His and Gin, respectively. This 
double mutant binds zinc and catalyzes the hydration of 
COs, suggesting that the structural similarities between CA 
and CARP include subtle features at the three-dimensional 
level. 
1. Introduction 
A number of proteins have been found to contain amino 
acid sequences with significant homologies with the sequences 
of various forms of the zinc-containing enzyme carbonic an- 
hydrase (CA, EC 4.2.1.1) from animal sources [1]. Most of 
these proteins lack one or more of the three histidines which 
act as zinc ligands in the functional enzyme. Since the metal 
ion is required for catalytic activity [2], and all three histidines 
are essential for tight zinc binding [3], it might be presumed 
that these proteins have little or no CO2 hydration activity. 
However, a human tumor-associated protein, MK, containing 
a CA-like domain, has been reported to have some activity, 
but all the zinc-binding histidines are conserved in this case 
[4]. 
One of the first of these CA-like proteins to be discovered 
was described by Kato [5], who obtained cDNA encoding a 
carbonic anhydrase-related protein (CARP) from a mouse 
brain cDNA library. He also showed that CARP is expressed 
in Purkinje cells. As yet, its function is unknown. The se- 
quence of the human homologue was reported by Skaggs et 
al. [6], who found a 98% sequence identity at the amino acid 
level with mouse CARP. Bergenhem et al. [7], who named the 
protein CA VII I  despite the fact that no CA activity has been 
demonstrated, have localized the human gene (CA8) to chro- 
mosome 8 at q l l  ~q12.  
CARP is an acidic protein, mainly depending on a gluta- 
mate-rich amino-terminal extension comprising about 25 res- 
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2. Materials and methods 
The cDNA encoding murine CARP was kindly provided by Dr. 
N.D. Carter, London, and had been cloned into the NotI site of the 
plasmid pBluescript KS(+) (Stratagene). To obtain efficent expression 
in Escherichia coli, we used the plasmid pACA1, which is derived 
from the plasmid pACA [8]. Like pACA, pACA1 contains the 
cDNA encoding human CA II under control of the T7 RNA poly- 
merase promoter, an F1 origin of replication allowing the production 
of single-stranded DNA, and a gene conferring ampicillin resistance. 
In pACA1, a HindlII site has been removed, and the plasmid has a 
single NcoI site located at the initiator ATG codon and a single 
HindlII site further downstream. The nucleotide sequence of the orig- 
inal CARP cDNA insert had no HindlII site but three NcoI sites 
located at the initiator ATG and at positions 412 and 482 in the 
coding region. The NcoI sites at positions 412 and 482 were removed 
by introducing 'silent' mutations and a HindIII site was introduced at 
position 984 downstream of the stop codon. The plasmid harboring 
the altered CARP cDNA and pACA1 were cleaved by NcoI and 
HindlII. The purified pACA1 fragment was ligated to the CARP 
DNA fragment using T4-DNA ligase. The mixture was used to trans- 
fect E. coli BL21(DE3) [9]. Positive colonies were identified by SDS- 
PAGE and Coomassie staining after growth in liquid cultures contain- 
ing ampicillin and induction of protein synthesis by IPTG. For a 
clone producing a 30 kDa protein in high yield the complete coding 
region was checked by plasmid sequencing before the clone was used 
for protein production. The plasmid was called pCARP. All nucleo- 
tide sequencing was performed using the chain termination method 
[10]. 
In vitro site-directed mutagenesis was performed essentially accord- 
ing to the method of Kunkel [11]. Uracil-containing single-stranded 
DNA of the plasmids pBluescript KS(+) and pCARP was produced in 
E. coli strain CJ236 (dut-, ung-) after infection with the helper phage 
M13K07. Mutants were obtained by in vitro second-strand synthesis 
from oligonucleotides containing mismatches. The resulting duplex 
DNA was transformed into E. coli (dut +, ung+), and mutations 
were then identified by direct sequencing of the plasmid DNA. 
CARP was produced in E. coli BL21(DE3) harboring the plasmid 
pCARP. The cells were grown at 23°C in 2 × Luria broth containing 
1 mM ZnSO4 and 50 ~tg/ml ampiciUin. Protein production was in- 
itiated by adding IPTG to a final concentration of 0.5 mM at a cell 
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density corresponding to OD66°=0.5 and then allowing the cells to 
grow for 12-14 h. The cells were broken using a Bead-Beater (Biospec 
Products, Bartlesville, OK). After removal of cell debris by centrifu- 
gation, the lysate was applied to an anion exchanger, Q-Sepharose 
(Pharmacia), equilibrated with 25 mM Mes-NaOH (pH 6.0) contain- 
ing 50 mM NaC1. The column was washed with the same buffer until 
the absorbance at 280 nm of the eluate was close to zero. Further 
washing was performed with five column volumes of 25 mM Mes- 
NaOH (pH 6.0) containing 250 mM NaC1. CARP was then eluted by 
five column volumes of the same buffer containing 300 mM NaC1. 
The fractions containing CARP were pooled, concentrated and passed 
through a gel-filtration column, Sephacryl 200 (Pharmacia), using a 
buffer of the same composition. SDS-PAGE analysis showed the pres- 
ence of some impurities after this step, but we estimated that CARP 
represented about 95% of the total protein. 
The extinction coefficient at 280 nm @280) of CARP was determined 
by the method of Gill and von Hippel [12] using the amino acid 
composition derived from the nucleotide sequence. Zinc analyses 
were performed at 213.9 nm with a Varian AA-375 atomic absorption 
spectrometer with an air-acetylene flame. All glassware had been 
treated with 2 M HNO3 to remove metal ion impurities. A 477A 
Pulsed Liquid Phase Sequencer with an online PTH 120A Analyzer 
(Applied Biosystems, Foster City, CA) was used for determination of
the N-terminal amino acid sequence. The protein was resolved by 
SDS-PAGE and transblotted onto a polyvinylidene difluoride mem- 
brane (0.2 ~tm) from where it was excised and eluted into solution. 
Sodium thioglycolate (0.1 mM) was included in all solutions to pre- 
vent oxidation of the protein. 
Initial rates of CO2 hydration were measured at 25°C in an Applied 
Photophysics DX.17MV stopped-flow apparatus (Leatherhead, UK) 
by the changing pH-indicator method [13]. The buffer-indicator sys- 
tem was Taps-NaOH/metacresol purple monitored at 578 rim. The 
ionic strength was kept at 0.1 M with NazSO4. Rate data were fitted 
to the Michaelis-Menten equation using the program GraFit (Eritha- 
cus Software Ltd., UK). 
3. Results 
The nucleotide sequence of the coding region of mouse 
CARP cDNA was found to be identical to that published 
by Kato [5] except at the positions engineered to remove re- 
striction sites (see Section 2) and at two additional positions. 
Thus, we found C instead of T at position 782. This involves a 
Va l~Ala  interchange at amino acid sequence position 261. 
Furthermore, we found an additional T after T s69. This would 
result in a 12-residue shorter polypeptide chain than the se- 
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Fig. l. Eadie-Hofstee plot of initial rates of CO2 hydration cata- 
lyzed by murine Glu n5 ~Gln/Arg u7 -~His CARP, (E), in 50 mM 
Taps-NaOH buffer at 25°C and pH 9.0. The ionic strength was 
kept at 0.1 M with Na2SO4. 
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Fig. 2. Inhibition by acetazolamide, (I), of CO2 hydration catalyzed 
by murine GluU~ ~ Gln/ArgU7 ~ His CARP in 50 mM Taps-NaOH 
buffer at 25°C and pH 9.0. The ionic strength was kept at 0.1 M 
with Na2SO4. The CO2 concentration was 16.8 mM and the concen- 
tration of the CARP mutant, (E), was 2.1 ~tM. 
quence derived by Kato, since a TAG stop codon would occur 
at nucleotide positions 874-876. Both of these sequence differ- 
ences were found for unmodified CARP as well as for the 
Glu 115 ---~Gln]Arg nT--)His mutant, so it seems unlikely that 
our results depend on sequencing errors. In addition, at these 
points our sequence corresponds exactly with that obtained by 
Skaggs et al. [6] for human CARP cDNA. 
The N-terminal amino acid sequence of purified CARP was 
found to be Ala-Asp-Leu-Ser-Phe- in accordance with the 
nucleotide sequence assuming that the initiator Met residue 
has been cleaved off. The resulting polypeptide should consist 
of 290 residues with a calculated molecular mass of 32 950 Da. 
The extinction coefficent of unmodified CARP at 280 nm 
(e2s0) was estimated as 48.0 mM -1 cm -1. The results of zinc 
analyses gave 0.12 mole of zinc per mole of unmodified CARP 
after dialysis against metal-depleted buffer, while the mutant 
contained 1.10 equivalents of zinc, indicating that a rather 
strong zinc-binding site has been created. 
Unmodified CARP showed no detectable CO2 hydration 
activity. However, the mutant is active. As shown in the Ea- 
die-Hofstee plot in Fig. 1, this 'reconstructed' CA follows 
Michaelis-Menten kinetics. Estimated values and standard er- 
rors are kc~t = (2.3 +_ 0.1).104 s -1, Km=22+l  mM, and kc~tl 
K~=(1.0+0.02)'106 M -1 s -a (25°C, pH 9.0). This activity 
could be inhibited by acetazolamide (2-acetylamido-l,3,4-thia- 
diazole-5-sulfonamide). The results illustrated in Fig. 2 de- 
monstrate that acetazolamide is a strong inhibitor of the 
CQ hydration activity of the mutant and that there is a 
1:1 stoichiometry between inhibitor and mutant protein. 
While several isozyme forms of CA are efficient catalysts of 
the hydrolysis of 4-nitrophenyl acetate, we could not detect 
any such esterase activity associated with the CARP mutant. 
4. Discussion 
The amino acid sequence of murine CARP derived from 
our nucleotide sequence differs from that of human CARP 
[6] in four places only, namely positions 10, 25, 109, and 
246. Thus, the degree of sequence identity is 98.6% on the 
amino acid level. Two of these positions, 10 and 25, are Io- 
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cated in the N-terminal extension, whose function is un- 
known. Preliminary results seem to exclude this glutamate- 
rich sequence as a calcium-binding region [14]. However, 
when applying the program PEST-FIND [15], we found that 
part of the N-terminal extension plus the first 30, or so, res- 
idues of the CA-homologous region is a potential PEST se- 
quence, indicating that this part of the protein might contain 
a degradation signal. The putative PEST sequence is as fol- 
lows. Note also the underlined 7-residue repeat. 
16-KEEDEEEEEEEGVEWGYEEGVEWGLVFPDANG- 
EYQSPINLNSR-58 
Our observation that two point mutations restore zinc bind- 
ing and catalytic activity to CARP is strong evidence that the 
three-dimensional structure of the active-site cavity of CA is 
well conserved in CARP. Additional evidence is provided by 
the strong inhibition of the activity by acetazolamide, a 
powerful and specific CA inhibitor [16]. After the initiation 
of our study, Kiefer et al. [17] have shown that the replace- 
ment of Gln 92 with Glu in human CA II has only a marginal 
effect on zinc affinity. Thus, it seems plausible that the single 
mutation, Arg la7---~ His, is sufficient to convert CARP to an 
active CA. We are presently testing this possibility. 
The COz hydration activity of the Glul lS~Gln/Arg 117 
His mutant is low compared to that of the most potent 
of the human CA isozymes, CA II, which has kcat = 1"106 s -1 
and kcJKm = 1"10 s M-is  -1 near pH 9 at 25°C [18]. However, 
the specific activity of the CARP mutant is significantly higher 
than that of one mammalian CA isozyme, namely the muscle- 
specific form, CA III. Bovine CA III, for example, was found 
to have kc~t=6.4.103 s -1 and kcJKr~=4.3"lO 5 M -1 s -1 at 
25°C and pH 8.9 [19]. Thus, the CARP mutant has 3.6 times 
the activity of bovine CA lII on the basis of kc~t and 2.3 times 
the activity on the basis of k~t/Km at pH near 9. 
In addition to some invariant amino acid residues, such as 
the zinc ligands and residues hydrogen bonded to them, the 
active sites of the CAs contain a number of residues howing 
a certain degree of interspecies and interisozyme variation 
[20]. At least some of these variations might be important 
for the fine tuning of the catalytic properties [21]. Most of 
the putative active-site residues in the CARP mutant fall with- 
in the range of these, previously observed, variations. For 
example, His ss in CARP corresponds to His 64 in CA II, where 
this residue has a crucial proton transfer ole during catalysis 
[22]. 
The only striking exception is Ile225 in CARP correspond- 
ing to residue 200 in CA. Most CA isozymes have threonine 
in this position, but all sequenced CAs I have His 2°°, which 
seems to be a major determinant of the specific properties of 
this isozyme [21,23]. A ThrZ°°~Ile mutant of human CA II 
has been produced, and it has a reduced CO2 hydration ac- 
tivity with koat about 20% and k~tlKm about 50% of the 
values for unmodified enzyme at 25°C and pH 8.9 [18]. This 
result suggests that it might be possible to increase the specific 
CO2 hydration activity of CARP further by introducing addi- 
tional mutations, uch as Ile225 ~Thr .  
Other candidates for further mutations of CARP are Ile 14z 
and I10 65 with positions homologous to those of Va1121 and 
Va1143, respectively, in human CA II. These residues form part 
of the wall of a hydrophobic pocket, where the substrate, 
CO2, has been assumed to bind [24,25]. With isoleucine in 
these two positions, it is probable that this pocket is smaller 
in the CARP mutant han in human CA II. In the human CA 
II framework, a Va1143-4 Ile mutation was found to have no 
effect on kcat for CO2 hydration, while a 9-fold increase of Km 
was observed, presumably as a consequence of the decreased 
size of the pocket [24]. The Va1121 --~ Ile mutant of human CA 
II was reported to have 15% of the CO2 hydration activity of 
the unmodified enzyme [8]. 
Another esidue which might have a modifying influence on 
the catalytic activity of the CARP mutant is Asp s6 with a 
sequence position homologous to that of residue 62 in CA. 
All sequenced CAs of the animal type have a neutral amino 
acid in this position, in most cases asparagine [1]. While the 
introduction of a negative charge near the zinc ion or in the 
substrate-binding pocket has a strong, detrimental effect on 
the catalytic activity [18,26], this residue is located in the outer 
part of the active-site cavity, and the effect of an Asn ~ Asp 
interchange is difficult to predict. 
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